Development of a new antiproliferative arachydonoylcyclopropilamide (ACPA) releasing nanoparticle-based drug for endometrial cancers by targeting cannabinoid 1 receptors

BİLGİÇ E., BOYACIOĞLU Ö., VARAN C., BİLENSOY E., NEMUTLU E., KARAOSMANOĞLU B., ...Daha Fazla

EACR Conference Nanotechnology in Cancer: Engineering for Oncology, 12 - 14 Eylül 2019

  • Yayın Türü: Bildiri / Özet Bildiri
  • Hacettepe Üniversitesi Adresli: Evet